Afatinib Completed Phase 2 Trials for Carcinoma, Squamous Cell of Head and Neck Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01415674Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC Patients
NCT01538381Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck